Literature DB >> 8644676

Comparison of infective endocarditis in patients with and without previously recognized heart disease.

C Selton-Suty1, B Hoen, F Delahaye, F Lacassin, V Goulet, J Etienne, S Briançon, C Leport.   

Abstract

In a consecutive series of patients with infective endocarditis, we compared the charts of 123 nonaddicted patients without previously known heart disease with those of 174 patients with native valve disease. The 2 groups were similar in age, sex, clinical findings, and mortality rates, but infective endocarditis was more often located on the aortic valve, more often due to Streptococcus bovis and enterococci in patients without previously known heart disease.

Entities:  

Mesh:

Year:  1996        PMID: 8644676     DOI: 10.1016/s0002-9149(96)00150-6

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Clinical and microbiologic features of multivalvular endocarditis.

Authors:  Christine Selton-Suty; Thanh Doco-Lecompte; Yvette Bernard; Xavier Duval; Lorraine Letranchant; François Delahaye; Marie Célard; François Alla; Jean-Pierre Carteaux; Bruno Hoen
Journal:  Curr Infect Dis Rep       Date:  2010-07       Impact factor: 3.725

2.  Ischemic stroke and splenic rupture in a case of Streptococcus bovis endocarditis.

Authors:  Claudia Stöllberger; Josef Finsterer; Angelika Pratter; Wolfgang Kopsa; Julius Preiser; Andreas Valentin
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

Review 3.  Infective endocarditis involving an apparently structurally normal valve: new epidemiological trend?

Authors:  Jae-Kwan Song
Journal:  Korean J Intern Med       Date:  2015-06-29       Impact factor: 2.884

4.  Incidence of infective endocarditis caused by viridans group streptococci in Sweden - effect of cessation of antibiotic prophylaxis in dentistry for risk individuals.

Authors:  Niko Vähäsarja; Bodil Lund; Anders Ternhag; Bengt Götrick; Lars Olaison; Margareta Hultin; Carina Krüger Weiner; Aron Naimi-Akbar
Journal:  J Oral Microbiol       Date:  2020-05-23       Impact factor: 5.474

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.